Cargando…

Electrophysiological differences between Hirayama disease, amyotrophic lateral sclerosis and cervical spondylotic amyotrophy

BACKGROUND: Hirayama disease (HD), amyotrophic lateral sclerosis (ALS) or cervical spondylotic amyotrophy (CSA) may result in atrophy of intrinsic hand and forearm muscles. The incidence of HD is low, and it is rarely encountered in the clinical setting. Consequently, HD is often misdiagnosed as ALS...

Descripción completa

Detalles Bibliográficos
Autores principales: Jin, Xiang, Jiang, Jian-Yuan, Lu, Fei-Zhou, Xia, Xin-Lei, Wang, Li-Xun, Zheng, Chao-Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4216382/
https://www.ncbi.nlm.nih.gov/pubmed/25319248
http://dx.doi.org/10.1186/1471-2474-15-349
_version_ 1782342253272891392
author Jin, Xiang
Jiang, Jian-Yuan
Lu, Fei-Zhou
Xia, Xin-Lei
Wang, Li-Xun
Zheng, Chao-Jun
author_facet Jin, Xiang
Jiang, Jian-Yuan
Lu, Fei-Zhou
Xia, Xin-Lei
Wang, Li-Xun
Zheng, Chao-Jun
author_sort Jin, Xiang
collection PubMed
description BACKGROUND: Hirayama disease (HD), amyotrophic lateral sclerosis (ALS) or cervical spondylotic amyotrophy (CSA) may result in atrophy of intrinsic hand and forearm muscles. The incidence of HD is low, and it is rarely encountered in the clinical setting. Consequently, HD is often misdiagnosed as ALS or CSA. It is important to differentiate these diseases because HD is caused by a benign focal lesion that is limited to the upper limbs. METHODS: The thenar and hypothenar compound muscle action potential (CMAP) amplitude of the upper limbs of 100 HD, 97 ALS and 32 CSA cases were reviewed; 35 healthy individuals were included as controls. Seventy-eight percent, 38% and 69% of patients with HD, ALS or CSA had unilateral involvement; the remaining patients were affected bilaterally. Thenar and hypothenar CMAP amplitude evoked by ulnar stimulation was compared with CMAP evoked by median stimulation. RESULTS: The ulnar/median CMAP ratio was found to be lower in HD (0.55 ± 0.41, P < 0.0001), higher in ALS (2.28 ± 1.15, P < 0.0001) and no different in CSA (1.21 ± 0.53, P > 0.05) compared with the normal range from previous studies (0.89-1.60) and with the healthy controls (1.15 ± 0.23). Conduction velocities of the sensory and motor nerves, the amplitude of the sensory nerve action potential, and the CMAP amplitude of the unaffected limb were all normal. CONCLUSIONS: The hand muscles were differentially affected between patients with HD, ALS and CSA. The ulnar/median CMAP ratio could be used to distinguish these three diseases.
format Online
Article
Text
id pubmed-4216382
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-42163822014-11-02 Electrophysiological differences between Hirayama disease, amyotrophic lateral sclerosis and cervical spondylotic amyotrophy Jin, Xiang Jiang, Jian-Yuan Lu, Fei-Zhou Xia, Xin-Lei Wang, Li-Xun Zheng, Chao-Jun BMC Musculoskelet Disord Research Article BACKGROUND: Hirayama disease (HD), amyotrophic lateral sclerosis (ALS) or cervical spondylotic amyotrophy (CSA) may result in atrophy of intrinsic hand and forearm muscles. The incidence of HD is low, and it is rarely encountered in the clinical setting. Consequently, HD is often misdiagnosed as ALS or CSA. It is important to differentiate these diseases because HD is caused by a benign focal lesion that is limited to the upper limbs. METHODS: The thenar and hypothenar compound muscle action potential (CMAP) amplitude of the upper limbs of 100 HD, 97 ALS and 32 CSA cases were reviewed; 35 healthy individuals were included as controls. Seventy-eight percent, 38% and 69% of patients with HD, ALS or CSA had unilateral involvement; the remaining patients were affected bilaterally. Thenar and hypothenar CMAP amplitude evoked by ulnar stimulation was compared with CMAP evoked by median stimulation. RESULTS: The ulnar/median CMAP ratio was found to be lower in HD (0.55 ± 0.41, P < 0.0001), higher in ALS (2.28 ± 1.15, P < 0.0001) and no different in CSA (1.21 ± 0.53, P > 0.05) compared with the normal range from previous studies (0.89-1.60) and with the healthy controls (1.15 ± 0.23). Conduction velocities of the sensory and motor nerves, the amplitude of the sensory nerve action potential, and the CMAP amplitude of the unaffected limb were all normal. CONCLUSIONS: The hand muscles were differentially affected between patients with HD, ALS and CSA. The ulnar/median CMAP ratio could be used to distinguish these three diseases. BioMed Central 2014-10-16 /pmc/articles/PMC4216382/ /pubmed/25319248 http://dx.doi.org/10.1186/1471-2474-15-349 Text en © Jin et al.; licensee BioMed Central Ltd. 2014 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Jin, Xiang
Jiang, Jian-Yuan
Lu, Fei-Zhou
Xia, Xin-Lei
Wang, Li-Xun
Zheng, Chao-Jun
Electrophysiological differences between Hirayama disease, amyotrophic lateral sclerosis and cervical spondylotic amyotrophy
title Electrophysiological differences between Hirayama disease, amyotrophic lateral sclerosis and cervical spondylotic amyotrophy
title_full Electrophysiological differences between Hirayama disease, amyotrophic lateral sclerosis and cervical spondylotic amyotrophy
title_fullStr Electrophysiological differences between Hirayama disease, amyotrophic lateral sclerosis and cervical spondylotic amyotrophy
title_full_unstemmed Electrophysiological differences between Hirayama disease, amyotrophic lateral sclerosis and cervical spondylotic amyotrophy
title_short Electrophysiological differences between Hirayama disease, amyotrophic lateral sclerosis and cervical spondylotic amyotrophy
title_sort electrophysiological differences between hirayama disease, amyotrophic lateral sclerosis and cervical spondylotic amyotrophy
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4216382/
https://www.ncbi.nlm.nih.gov/pubmed/25319248
http://dx.doi.org/10.1186/1471-2474-15-349
work_keys_str_mv AT jinxiang electrophysiologicaldifferencesbetweenhirayamadiseaseamyotrophiclateralsclerosisandcervicalspondyloticamyotrophy
AT jiangjianyuan electrophysiologicaldifferencesbetweenhirayamadiseaseamyotrophiclateralsclerosisandcervicalspondyloticamyotrophy
AT lufeizhou electrophysiologicaldifferencesbetweenhirayamadiseaseamyotrophiclateralsclerosisandcervicalspondyloticamyotrophy
AT xiaxinlei electrophysiologicaldifferencesbetweenhirayamadiseaseamyotrophiclateralsclerosisandcervicalspondyloticamyotrophy
AT wanglixun electrophysiologicaldifferencesbetweenhirayamadiseaseamyotrophiclateralsclerosisandcervicalspondyloticamyotrophy
AT zhengchaojun electrophysiologicaldifferencesbetweenhirayamadiseaseamyotrophiclateralsclerosisandcervicalspondyloticamyotrophy